News
Drug repurposing: new opportunities for cancer patients
Computational approach to drug repurposing predicts that a significant 14% of patients could be treated with proven therapies.
Dr. Meritxell Rovira, awarded with the “CRIS de Excelencia” Program to study pancreatic cancer
The recognition granted by the CRIS Foundation against cancer aims to promote and consolidate the careers of researchers with an endowment of up to 1,250,000 euros.
An innovative therapeutic strategy to treat colon cancer is discovered
The study has identified how the combination of inhibitors of PP2A and WEE1 proteins induces the death of colon cancer cells, offering a new perspective in the treatment of this disease.
The complex relationship between obesity and certain EDs, under the spotlight
The need for a comprehensive study of obesity and EDs is becoming increasingly apparent.
Against misinformation, VacunAcció
The scientific and artistic high school students from Institut Bellvitge have created awareness campaigns about vaccination within the framework of the 4th edition of VacunAcció.
IDIBELL promotes physical activity on World Health Day
Although a sedentary lifestyle is one of the main risk factors for many diseases, 47% of the Spanish population never engage in physical activity.
Breast cancer patients highly satisfied with micropigmentation and nipple and areola reconstruction, study finds
Patients undergoing reconstructive breast surgery show a high degree of satisfaction with micropigmentation and surgical reconstruction of the areola and nipple, according to a study led by the GRIN – IDIBELL and HUB nursing research group.
IDIBELL and BST generate a bank of stem cells that can be used as precursors for cell therapy
Scientists have generated seven pluripotent stem cell lines compatible with 20% of the Spanish population
New step in understanding the influence of genes on cancer risk
Certain variations in our DNA, which had previously gone unnoticed, can have a significant impact on the development of cancer.